Pressroom

See all trending topics »Trending Topics

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator »

Exciting Developments, New Research in Breast Cancer: San Antonio Breast Cancer Symposium

Memorial Sloan Kettering breast cancer experts are available to comment on breaking news out of this year’s annual meeting set to take place December 9 through 13.

Monday, December 8, 2014
Major Developments in Hematology-Oncology to Be Reported at ASH Annual Meeting

The largest hematology-oncology meeting in the world will take place in San Francisco from December 6 through 9. Memorial Sloan Kettering experts are available to comment on breaking news out of the meeting.

Tuesday, December 2, 2014
Memorial Sloan Kettering Team Makes Key Discovery in Understanding Immunotherapy’s Successes—And Its Failures

A collaborative team of leaders in the field of cancer immunology has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do not.

Wednesday, November 19, 2014

See all press releases »Press Releases

Memorial Sloan Kettering Debuts New Mobile Application for Patients

Memorial Sloan Kettering Cancer Center (MSK) has debuted MyMSK, a new mobile application. The app, compatible with iPad, iPhone, and all iOS devices, allows MSK patients to quickly and easily access their lab and radiology results, view their upcoming appointments, record their medications and symptoms in online diaries, communicate with their healthcare team, and more.

Monday, February 23, 2015
Memorial Sloan Kettering Cancer Center and Weill Cornell to Co-Lead Tuberculosis Research Unit

In an effort to stop tuberculosis (TB) from becoming progressively less treatable worldwide, the National Institutes of Health is funding a research collaboration among six institutions in close alliance. The total funding, provided by the National Institute of Allergy and Infectious Diseases, could be up to $45.7 million over seven years.

Wednesday, February 18, 2015
Pictured: Eytan Stein
Memorial Sloan Kettering Study Shows New Kind of Targeted Drug Has Promise for Leukemia Patients

A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial.

Sunday, December 7, 2014

See all story starters »Story Starters

Need story ideas? Use our evergreen story suggestions to generate new content or complement something you're already working on.

See all blog posts »On Our Blog

Surgeon Larissa Temple
Support
New Survey Helps Doctors Better Assess Outcomes for Rectal Cancer Surgery

A new online survey aims to provide doctors with real-time information on their patients’ quality of life after rectal surgery.

Thursday, February 26, 2015
Peter Scardino, Chair of MSK’s Department of Surgery and a specialist in the treatment of prostate cancers.
Q&A
Predicting the Future of Cancer Surgery

Peter Scardino, Chair of MSK’s Department of Surgery, gives his views on what lies ahead for the surgical treatment of cancer.

Tuesday, February 24, 2015
NYC Chinatown
In the Clinic
Straight Talk: Connecting with Patients in Their Own Languages

Services including a pilot program for remote simultaneous medical interpreting using UN-style headsets can help improve care for a growing number of patients.

Thursday, February 19, 2015

MSK News Highlights

Watch highlights including news coverage of recent scientific and clinical developments at Memorial Sloan Kettering, our physicians and scientists in the national spotlight, and our amazing staff and programs.

Watch Video »

See all media coverage »Media Coverage

U.S. to Collect Genetic Data to Hone Care

Medical oncologist José Baselga discusses President Obama’s announcement about precision medicine.

Saturday, January 31, 2015
Prostate Cancer Patients Who Smoke Fare Worse, Study Finds

Radiation oncologist Michael Zelefsky discusses his recent study published in the journal BMJ.

Tuesday, January 27, 2015
Optimal Treatment Timing Improves Outcome in Rectal Cancer

Medical oncologist Nancy Kemeny was interviewed about how timing plays an important role between radiation therapy and surgery in patients with rectal cancer.

Saturday, January 24, 2015

For Journalists

Contact Media Staff

Jeanne D'Agostino
Media Relations Manager
Emily O'Donnell
Senior Communications Associate, Department of Surgery
Courtney Nowak
Senior Media Relations Associate
Caitlin Hool
Senior Media Associate
Rebecca Williams
Media Associate

For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.

After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

#1 in Cancer Care

MSK Named #1 by U.S. News

News & World Report named Memorial Sloan Kettering the top hospital for cancer care in the nation. We're honored, and patient care will always be our top priority.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

Subscribe to Our
E-Newsletter

Our e-mail newsletter for journalists offers the latest advances in cancer research and treatment, including story ideas, institutional milestones and plans, and newsworthy staff accomplishments.

Sign Up

Read recent issues »